{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:06:11Z","timestamp":1761843971809},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.intimp.2010.03.007","type":"journal-article","created":{"date-parts":[[2010,3,23]],"date-time":"2010-03-23T10:55:21Z","timestamp":1269341721000},"page":"713-716","source":"Crossref","is-referenced-by-count":11,"title":["Effect of 5-aminosalicylate on allergic rhinitis model in mice"],"prefix":"10.1016","volume":"10","author":[{"given":"Shoji","family":"Kuyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayu","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Kakuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2010.03.007_bib1","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1073\/pnas.91.15.7355","article-title":"Differential expression and activation of a family of murine peroxisome proliferator-activated receptors","volume":"91","author":"Kliewer","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.intimp.2010.03.007_bib2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pharmthera.2005.08.007","article-title":"Peroxisome proliferator-activated receptors and inflammation","volume":"110","author":"Moraes","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.intimp.2010.03.007_bib3","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1365-2222.2006.02604.x","article-title":"Peroxisome proliferator-activated receptor-\u03b3 agonists as potential anti-inflammatory agents in asthma and chronic obstructive pulmonary disease","volume":"36","author":"Spears","year":"2006","journal-title":"Clin Exp Allergy"},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2010.03.007_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000077790","article-title":"Peroxisome proliferator-activated receptor \u03b3 regulates eosinophil functions: a new therapeutic target for allergic airway inflammation","volume":"134","author":"Ueki","year":"2004","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.intimp.2010.03.007_bib5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.otohns.2008.03.030","article-title":"The effects of peroxisome proliferator-activated receptor-gamma agonist on a murine model of experimental allergic rhinitis","volume":"139","author":"Jeon","year":"2008","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.intimp.2010.03.007_bib6","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1177\/147323000803600426","article-title":"Rosiglitazone attenuates allergic inflammation and inhibits expression of galectin-3 in a mouse model of allergic rhinitis","volume":"36","author":"Han","year":"2008","journal-title":"J Int Med Res"},{"key":"10.1016\/j.intimp.2010.03.007_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2332\/allergolint.08-OA-0047","article-title":"Peroxisome proliferator-activated receptor \u03b3 negatively regulates allergic rhinitis in mice","volume":"58","author":"Fukui","year":"2009","journal-title":"Allergol Int"},{"key":"10.1016\/j.intimp.2010.03.007_bib8","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.bbalip.2007.02.003","article-title":"Safety issues and prospects for future generations of PPAR modulators","volume":"1771","author":"Rubenstrunk","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.intimp.2010.03.007_bib9","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1463-1326.2006.00616.x","article-title":"PPARgamma agonists: safety issues in heart failure","volume":"9","author":"Tang","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.intimp.2010.03.007_bib10","doi-asserted-by":"crossref","first-page":"943614","DOI":"10.1155\/2008\/943614","article-title":"Renal and vascular mechanisms of thiazolidinedione-induced fluid retention","volume":"2008","author":"Yang","year":"2008","journal-title":"PPAR Res"},{"key":"10.1016\/j.intimp.2010.03.007_bib11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/dmrr.937","article-title":"Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications","volume":"25","author":"Krentz","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.intimp.2010.03.007_bib12","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.20041948","article-title":"Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma","volume":"201","author":"Rousseaux","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.intimp.2010.03.007_bib13","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1136\/gut.2006.093484","article-title":"PPAR\u03b3 as a new therapeutic target in inflammatory bowel diseases","volume":"55","author":"Dubuquoy","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.intimp.2010.03.007_bib14","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4049\/jimmunol.156.1.218","article-title":"Inhibitory effects of sulfasalazine and its metabolites on histamine release and TNF-alpha production by mast cells","volume":"156","author":"Bissonnette","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2010.03.007_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-2999(85)90071-8","article-title":"Inhibition of IgE-mediated mast cell degranulation by sulphasalazine","volume":"107","author":"Barrett","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.intimp.2010.03.007_bib16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1254\/jphs.08164FP","article-title":"Participation of histamine H3 receptors in experimental allergic rhinitis of mice","volume":"108","author":"Yokota","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.intimp.2010.03.007_bib17","first-page":"351","article-title":"Release of platelet-activating factor (PAF) from human colon mucosa and its inhibition by 5-aminosalicylic acid","volume":"17","author":"Capasso","year":"1991","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.intimp.2010.03.007_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF01300753","article-title":"Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid","volume":"36","author":"Fox","year":"1991","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.intimp.2010.03.007_bib19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2500\/105065800781329483","article-title":"Pathogenic mechanisms underlying the clinical symptoms of allergic rhinitis","volume":"14","author":"Wang","year":"2000","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.intimp.2010.03.007_bib20","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.2165\/00003495-200767180-00006","article-title":"Histamine and leukotriene receptor antagonism in the treatment of allergic rhinitis: an update","volume":"67","author":"Van Hoecke","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.intimp.2010.03.007_bib21","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1398-9995.2008.01831.x","article-title":"Nerve growth factor localization in the nasal mucosa of patients with persistent allergic rhinitis","volume":"64","author":"Bresciani","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2010.03.007_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1067\/mai.2003.1554","article-title":"TNF-alpha contributes to the development of allergic rhinitis in mice","volume":"112","author":"Iwasaki","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2010.03.007_bib23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.molmed.2008.07.002","article-title":"Interpreting crosstalk between TNF-alpha and NGF: potential implications for disease","volume":"14","author":"Takei","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.intimp.2010.03.007_bib24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2174\/156652408785160907","article-title":"Role of IL-10 in the resolution of airway inflammation","volume":"8","author":"Ogawa","year":"2008","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.intimp.2010.03.007_bib25","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1398-9995.2008.01677.x","article-title":"Activation of peroxisome proliferator-activated receptor gamma suppresses mast cell maturation involved in allergic diseases","volume":"63","author":"Tachibana","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2010.03.007_bib26","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archotol.132.11.1196","article-title":"S, Woo JS et al. Up-regulation of peroxisome proliferator-activated receptor \u03b3 in perennial allergic rhinitis","volume":"132","author":"Kang","year":"2006","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.intimp.2010.03.007_bib27","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1002\/1521-4141(2000012)30:12<3363::AID-IMMU3363>3.0.CO;2-B","article-title":"Peroxisome proliferator-activated receptors are expressed in human cultured mast cells: a possible role of these receptors in negative regulation of mast cell activation","volume":"30","author":"Sugiyama","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2010.03.007_bib28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1254\/jphs.FMJ04008X6","article-title":"Nuclear receptors as targets for drug development: peroxisome proliferator-activated receptor gamma in mast cells: its roles in proliferation and differentiation","volume":"97","author":"Maeyama","year":"2005","journal-title":"J Pharmacol Sci"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576910000913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576910000913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T05:10:01Z","timestamp":1685509801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576910000913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1567576910000913"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2010.03.007","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}